These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33022026)

  • 1. A protocol for the development and internal validation of a model to predict clinical response to antihistamines in urticaria patients.
    Sanchez J; Velasquez M; Jaimes F
    PLoS One; 2020; 15(10):e0239962. PubMed ID: 33022026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation.
    Sánchez J; Jaimes F; García E; Zakzuk J; Cardona R; Velasquez M
    PLoS One; 2024; 19(2):e0295791. PubMed ID: 38394074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics.
    Zuberbier T; Peter J; Staubach P; Chularojanamontri L; Kulthanan K
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2265-2273. PubMed ID: 37356753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of omalizumab to antihistamine treatment in chronic urticaria: A real-world study in China.
    Chen YD; Maurer M; Yu M; Tu P; Zhao ZT
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):217-219. PubMed ID: 32371240
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors Associated With Refractoriness to an Up to Fourfold Dosage of Antihistamines in Isolated Chronic Spontaneous Urticaria.
    Wongjirattikarn R; Chaowattanapanit S; Foocharoen C; Sawanyawisuth K; Choonhakarn C; Julanon N; Utchariyaprasit E
    J Cutan Med Surg; 2022; 26(6):593-599. PubMed ID: 36172833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.
    Sánchez J; Zakzuk J; Cardona R
    J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-epidemiological features of chronic urticaria in children: A retrospective analysis of 296 children from a tertiary care institute in Northern India.
    Kumaran MS; Mahajan R; Goyal N; Parsad D
    Indian J Dermatol Venereol Leprol; 2020; 86(1):50-54. PubMed ID: 30264742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxepin in difficult-to-treat chronic urticaria: A retrospective, cross-sectional study from Turkey.
    Özkaya E; Babuna Kobaner G; Yılmaz Z; Kutlay A
    Dermatol Ther; 2019 Jul; 32(4):e12993. PubMed ID: 31175673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience of a chronic urticaria referral university center.
    Andrade Coelho Dias G; Cunha Coelho F; Filippo P; Lacerda Pedrazzi D; Nogueira Arraes AC; Perelló MI; Chigres Kuschnir F; Costa E
    Eur Ann Allergy Clin Immunol; 2020 May; 52(3):112-120. PubMed ID: 31287262
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical difference between single subtype and mixed subtype chronic urticaria: A retrospective study.
    Mao M; Yuan Y; Xiao Y; Peng C; Chen X; Li J
    Indian J Dermatol Venereol Leprol; 2022; 88(2):171-176. PubMed ID: 34491667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.
    Salman A; Ergun T; Gimenez-Arnau AM
    J Dermatolog Treat; 2020 Mar; 31(2):204-209. PubMed ID: 30821591
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed Pressure Urticaria: Clinical and Diagnostic Features and Response to Omalizumab.
    Veleiro-Pérez B; Alba-Muñoz J; Pérez-Quintero O; Rodríguez RL; Calvín-Lamas M; Parra-Arrondo A
    Int Arch Allergy Immunol; 2022; 183(10):1089-1094. PubMed ID: 35609554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL; Li JTS; Leung AKC; Lee VWY
    Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria.
    Özen B; Sancakli O; Duman Senol H; Ozdogru EE; Tuncel T
    Dermatol Ther; 2022 Mar; 35(3):e15261. PubMed ID: 34907626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
    Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
    Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inducible urticaria: confirmation through challenge tests and response to treatment.
    Pereira ARF; Motta AA; Kalil J; Agondi RC
    Einstein (Sao Paulo); 2020; 18():eAO5175. PubMed ID: 32667419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
    Melé-Ninot G; Serra-Baldrich E; Spertino J; Guilarte M; Ribó González P; Lleonart-Bellfill R; Figueras-Nart I; Bonfill-Ortí M; Depreux N; Sala-Cunill A; Bielsa-Marsol I; Baliu-Piqué C; Sanmartín-Novell V; Garcia-Navarro X; Expósito-Serrano V; Garnica-Velandia D; Diaz-Sarrió MC; Gómez-Armayones S; Gich Saladich I; Giménez-Arnau A
    Eur J Dermatol; 2022 Sep; 32(5):629-631. PubMed ID: 36468733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of atorvastatin and antihistamines in comparison with antihistamines plus placebo in the treatment of chronic idiopathic urticaria: a controlled clinical trial.
    Pezeshkpoor F; Farid Hosseini R; Rafatpanah H; Shakerian B; Jabbari F; Zandkarimi MR; Yousefzadeh H; Sadri H; Bahrami A; Zamani MA
    Iran J Allergy Asthma Immunol; 2012 Sep; 11(3):236-40. PubMed ID: 22947909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S; Orcen C; Church MK; Kocaturk E
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response.
    Özçeker D; Can PK; Terzi Ö; Ornek SA; Değirmentepe EN; Kızıltac K; Sarac E; Kocatürk E
    Pediatr Allergy Immunol; 2023 Feb; 34(2):e13925. PubMed ID: 36825740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.